137 related articles for article (PubMed ID: 30262404)
21. Molecular correlates of invasion pattern in HPV-associated endocervical adenocarcinoma: emergence of two distinct risk-stratified tiers.
Sharma AE; Hodgson AJ; Howitt BE; Olkhov-Mitsel E; Djordevic B; Park KJ; Nucci MR; Parra-Herran C
Histopathology; 2023 Jun; 82(7):1067-1078. PubMed ID: 36849702
[TBL] [Abstract][Full Text] [Related]
22. Significant effects of lymph and blood vascular invasion on the prognosis of early-stage cervical squamous cell carcinoma.
Zhang Y; Yan M; He J; Sun J; Sun X
J Obstet Gynaecol Res; 2010 Oct; 36(5):1015-22. PubMed ID: 20846259
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of solitary lymph node metastasis in patients with stages IA2 to IIA cervical carcinoma.
Dai YF; Xu M; Zhong LY; Xie XY; Liu ZD; Yan MX; Yi H; Lin DM
J Int Med Res; 2018 Oct; 46(10):4082-4091. PubMed ID: 29963935
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic factors of endocervical type adenocarcinoma in uterine cervix].
Yokosuka K; Hasumi K
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Sep; 46(9):889-95. PubMed ID: 7963889
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
26. Histopathological factors influencing pelvic lymph node metastases in two or more sites in patients with cervical carcinoma undergoing radical hysterectomy.
Kamura T; Shigematsu T; Kaku T; Shimamoto T; Saito T; Sakai K; Mitsumoto M; Nakano H
Acta Obstet Gynecol Scand; 1999 May; 78(5):452-7. PubMed ID: 10326894
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors of adenocarcinoma of the uterine cervix.
Ishikawa H; Nakanishi T; Inoue T; Kuzuya K
Gynecol Oncol; 1999 Apr; 73(1):42-6. PubMed ID: 10094878
[TBL] [Abstract][Full Text] [Related]
28. Pattern-based classification of invasive endocervical adenocarcinoma, depth of invasion measurement and distinction from adenocarcinoma in situ: interobserver variation among gynecologic pathologists.
Parra-Herran C; Taljaard M; Djordjevic B; Reyes MC; Schwartz L; Schoolmeester JK; Lastra RR; Quick CM; Laury A; Rasty G; Nucci MR; Howitt BE
Mod Pathol; 2016 Aug; 29(8):879-92. PubMed ID: 27174588
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
30. The pattern is the issue: recent advances in adenocarcinoma of the uterine cervix.
Roma AA; Fadare O
Virchows Arch; 2018 Jun; 472(6):897-905. PubMed ID: 29404709
[TBL] [Abstract][Full Text] [Related]
31. Well-Differentiated villoglandular adenocarcinoma of the uterine cervix: a report of 15 cases including two with lymph node metastasis.
Khunamornpong S; Maleemonkol S; Siriaunkgul S; Pantusart A
J Med Assoc Thai; 2001 Jun; 84(6):882-8. PubMed ID: 11556470
[TBL] [Abstract][Full Text] [Related]
32. Stage I cervical adenocarcinoma: prognostic evaluation of surgically treated patients.
Matthews CM; Burke TW; Tornos C; Eifel PJ; Atkinson EN; Stringer CA; Morris M; Silva EG
Gynecol Oncol; 1993 Apr; 49(1):19-23. PubMed ID: 8482554
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of prognostic factors in 159 cases of cervical adenocarcinoma].
Li H; Zhang WH; Zhang R; Wu LY; Li XG; Bai P
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):235-8. PubMed ID: 15924668
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery.
McLellan R; Dillon MB; Woodruff JD; Heatley GJ; Fields AL; Rosenshein NB
Gynecol Oncol; 1994 Feb; 52(2):253-9. PubMed ID: 8314148
[TBL] [Abstract][Full Text] [Related]
36. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).
Stolnicu S; Hoang L; Chiu D; Hanko-Bauer O; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Soslow RA
Am J Surg Pathol; 2019 Apr; 43(4):466-474. PubMed ID: 30720532
[TBL] [Abstract][Full Text] [Related]
37. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
[TBL] [Abstract][Full Text] [Related]
38. Early invasive cervical adenocarcinoma: its potential for nodal metastasis or recurrence.
Hirai Y; Takeshima N; Tate S; Akiyama F; Furuta R; Hasumi K
BJOG; 2003 Mar; 110(3):241-6. PubMed ID: 12628261
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.
Mabuchi S; Okazawa M; Kinose Y; Matsuo K; Fujiwara M; Suzuki O; Morii E; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497
[TBL] [Abstract][Full Text] [Related]
40. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
